Search This Blog

Wednesday, November 6, 2019

Horizon Pharma EPS beats by $0.14, beats on revenue

Horizon Pharma (NASDAQ:HZNP): Q3 Non-GAAP EPS of $0.64 beats by $0.14; GAAP EPS of $0.09 beats by $0.02.
Revenue of $335.5M (+3.1% Y/Y) beats by $4.9M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)